Bausch Health Cos., Inc. (BHC.TO)
11.91
+0.15
(+1.28%)
CAD |
TSX |
Nov 13, 16:00
Bausch Health Cos. Enterprise Value : 31.74B for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 31.74B |
| November 12, 2026 | 31.68B |
| November 11, 2026 | 31.74B |
| November 10, 2026 | 31.69B |
| November 09, 2026 | 31.73B |
| November 06, 2026 | 31.61B |
| November 05, 2026 | 31.47B |
| November 04, 2026 | 31.65B |
| November 03, 2026 | 31.55B |
| November 02, 2026 | 31.49B |
| October 30, 2026 | 31.57B |
| October 29, 2026 | 31.92B |
| October 28, 2026 | 30.90B |
| October 27, 2026 | 30.60B |
| October 26, 2026 | 30.61B |
| October 23, 2026 | 30.66B |
| October 22, 2026 | 30.68B |
| October 21, 2026 | 30.67B |
| October 20, 2026 | 30.65B |
| October 19, 2026 | 30.63B |
| October 16, 2026 | 30.62B |
| October 15, 2026 | 30.64B |
| October 14, 2026 | 30.42B |
| October 13, 2026 | 30.41B |
| October 09, 2026 | 30.51B |
| Date | Value |
|---|---|
| October 08, 2026 | 30.50B |
| October 07, 2026 | 30.57B |
| October 06, 2026 | 30.48B |
| October 05, 2026 | 30.43B |
| October 02, 2026 | 30.37B |
| October 01, 2026 | 30.32B |
| September 30, 2026 | 30.38B |
| September 29, 2026 | 31.31B |
| September 28, 2026 | 31.31B |
| September 25, 2026 | 31.26B |
| September 24, 2026 | 31.23B |
| September 23, 2026 | 31.25B |
| September 22, 2026 | 31.30B |
| September 21, 2026 | 31.21B |
| September 18, 2026 | 31.21B |
| September 17, 2026 | 31.21B |
| September 16, 2026 | 31.23B |
| September 15, 2026 | 31.19B |
| September 14, 2026 | 31.33B |
| September 11, 2026 | 31.28B |
| September 10, 2026 | 31.40B |
| September 09, 2026 | 31.43B |
| September 08, 2026 | 31.56B |
| September 04, 2026 | 31.63B |
| September 03, 2026 | 31.73B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| HLS Therapeutics, Inc. | 154.12M |
| Cipher Pharmaceuticals, Inc. | 336.68M |
| BioSyent, Inc. | 195.94M |
| Revive Therapeutics Ltd. | 6.520M |
| Knight Therapeutics, Inc. | 1.082B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 624.37M |
| Revenue (Quarterly) | 4.117B |
| Total Expenses (Quarterly) | 3.507B |
| EPS Diluted (Quarterly) | 1.603 |
| Gross Profit Margin (Quarterly) | 67.29% |
| Profit Margin (Quarterly) | 15.16% |
| Earnings Yield | -26.11% |
| Operating Earnings Yield | 93.81% |
| Normalized Earnings Yield | 12.71 |